VELA Investment Management LLC Acquires Shares of 80,120 DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

VELA Investment Management LLC acquired a new stake in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 80,120 shares of the medical instruments supplier’s stock, valued at approximately $2,168,000.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the stock. First Eagle Investment Management LLC raised its stake in shares of DENTSPLY SIRONA by 33.6% during the 2nd quarter. First Eagle Investment Management LLC now owns 13,069,900 shares of the medical instruments supplier’s stock worth $325,571,000 after buying an additional 3,283,965 shares in the last quarter. Nuance Investments LLC raised its stake in shares of DENTSPLY SIRONA by 3.8% during the 2nd quarter. Nuance Investments LLC now owns 10,879,916 shares of the medical instruments supplier’s stock worth $271,019,000 after buying an additional 402,329 shares in the last quarter. Cooke & Bieler LP raised its stake in shares of DENTSPLY SIRONA by 16.2% during the 2nd quarter. Cooke & Bieler LP now owns 7,506,845 shares of the medical instruments supplier’s stock worth $186,996,000 after buying an additional 1,046,105 shares in the last quarter. Price T Rowe Associates Inc. MD raised its stake in shares of DENTSPLY SIRONA by 5.8% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 6,266,781 shares of the medical instruments supplier’s stock worth $207,995,000 after buying an additional 343,915 shares in the last quarter. Finally, Dimensional Fund Advisors LP raised its stake in shares of DENTSPLY SIRONA by 42.0% during the 2nd quarter. Dimensional Fund Advisors LP now owns 4,420,445 shares of the medical instruments supplier’s stock worth $110,118,000 after buying an additional 1,308,411 shares in the last quarter. 95.70% of the stock is owned by hedge funds and other institutional investors.

DENTSPLY SIRONA Price Performance

NASDAQ:XRAY traded up $0.32 during trading hours on Friday, reaching $23.49. 2,328,568 shares of the company traded hands, compared to its average volume of 2,225,088. DENTSPLY SIRONA Inc. has a 1-year low of $22.85 and a 1-year high of $37.60. The firm’s 50-day moving average is $25.08 and its 200-day moving average is $26.22. The company has a debt-to-equity ratio of 0.57, a current ratio of 1.33 and a quick ratio of 0.87. The stock has a market cap of $4.76 billion, a P/E ratio of -27.31, a P/E/G ratio of 1.26 and a beta of 1.02.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its quarterly earnings data on Wednesday, July 31st. The medical instruments supplier reported $0.49 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.50 by ($0.01). DENTSPLY SIRONA had a positive return on equity of 11.86% and a negative net margin of 4.75%. The business had revenue of $984.00 million for the quarter, compared to analyst estimates of $993.61 million. During the same quarter last year, the business earned $0.51 EPS. DENTSPLY SIRONA’s revenue for the quarter was down 4.3% compared to the same quarter last year. Equities research analysts expect that DENTSPLY SIRONA Inc. will post 1.98 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several research firms recently weighed in on XRAY. Barrington Research reaffirmed an “outperform” rating and issued a $36.00 price objective on shares of DENTSPLY SIRONA in a research note on Friday, September 20th. Evercore ISI dropped their price objective on DENTSPLY SIRONA from $29.00 to $27.00 and set an “outperform” rating for the company in a research note on Tuesday, October 8th. Stifel Nicolaus dropped their price objective on DENTSPLY SIRONA from $30.00 to $28.00 and set a “hold” rating for the company in a research note on Thursday, July 18th. Robert W. Baird dropped their price objective on DENTSPLY SIRONA from $33.00 to $31.00 and set a “neutral” rating for the company in a research note on Monday, July 22nd. Finally, Needham & Company LLC dropped their price objective on DENTSPLY SIRONA from $34.00 to $29.00 and set a “buy” rating for the company in a research note on Friday, October 25th. Four investment analysts have rated the stock with a hold rating and eight have assigned a buy rating to the stock. According to data from MarketBeat.com, DENTSPLY SIRONA presently has a consensus rating of “Moderate Buy” and a consensus target price of $32.67.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.